Advertisement

Cytotechnology

, Volume 15, Issue 1–3, pp 31–50 | Cite as

Diverse effects of essential (n−6 andn−3) fatty acids on cultured cells

  • Stephanos I. Grammatikos
  • Papasani V. Subbaiah
  • Thomas A. Victor
  • William M. Miller
Article

Abstract

Fatty acids (FAs) have long been recognized for their nutritional value in the absence of glucose, and as necessary components of cell membranes. However, FAs have other effects on cells that may be less familiar. Polyunsaturated FAs of dietary origin (n−6 andn−3) cannot be synthesized by mammals, and are termed ‘essential’ because they are required for the optimal biologic function of specialized cells and tissues. However, they do not appear to be necessary for normal growth and metabolism of a variety of cells in culture. The essential fatty acids (EFAs) have received increased attention in recent years due to their presumed involvement in cardiovascular disorders and in cancers of the breast, pancreas, colon and prostate. Manyin vitro systems have emerged which either examine the role of EFAs in human disease directly, or utilize EFAs to mimic thein vivo cellular environment. The effects of EFAs on cells are both direct and indirect. As components of membrane phospholipids, and due to their varying structural and physical properties, EFAs can alter membrane fluidity, at least in the local environment, and affect any process that is mediated via the membrane. EFAs containing 20 carbons and at least three double bonds can be enzymatically converted to eicosanoid hormones, which play important roles in a variety of physiological and pathological processes. Alternatively, EFAs released into cells from phospholipids can act as second messengers that activate protein kinase C. Furthermore, susceptibility to oxidative damage increases with the degree of unsaturation, a complication that merits consideration because lipid peroxidation can lead to a variety of substances with toxic and mutagenic properties. The effects of EFAs on cultured cells are illustrated using the responses of normal and tumor human mammary epithelial cells. A thorough evaluation of EFA effects on commercially important cells could be used to advantage in the biotechnology industry by identifying EFA supplements that lead to improved cell growth and/or productivity.

Key words

Desaturation eicosanoids lipid peroxidation membrane fluidity protein kinase C serum-free medium 

Abbreviations

AA

arachidonic acid (20 carbons: 4 double bonds,n−6)

BHA

butylated hydroxyanisole

BHT

butylated hydroxytoluene

cAMP

cyclic adenosine monophosphate

CHO

Chinese hamster ovary

DAG

diacylglycerol

DGLNA

dihomo-γ-linolenic acid (20∶3,n−6)

DHA

docosahexaenoic acid (22∶6,n−3)

EFA

essential fatty acid

EGF

epidermal growth factor

EGFR

epidermal growth factor receptor

EPA

eicosapentaenoic acid (20∶5,n−3)

FA

fatty acid

FBS

fetal bovine serum

GLNA

γ-linolenic acid (18∶3,n−6)

LA

linoleic acid (18∶2,n−6)

LNA

α-linolenic acid (18∶3,n−3)

LT

leukotriene

MDA

malondialdehyde

NAD

nicotinamide adenine dinucleotide

NDGA

nordihydroguaiaretic acid

OA

oleic acid (18∶1,n−9)

PG

prostaglandin

PKC

protein kinase C

PUFA

polyunsaturated fatty acid

SFM

serum-free medium

TX

thromboxane

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdel-Malek ZA, Swope YB, Amornsiripanitch N and Nordlund JJ (1987)In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins. Cancer Res 47: 3141–3146.Google Scholar
  2. Arita H, Nahano T and Hanasaki K (1989) Thrombaxane A2: its generation and role in platelet activation. Prog Lipid Res 28: 273–301.Google Scholar
  3. Bach MK (1984) The Leukotrienes. Academic, New York.Google Scholar
  4. Bailey JM and Dunbar LM (1973) Essential fatty acid requirements of cells in tissue culture: A review. Exp Mol Pathol 18: 142–161.Google Scholar
  5. Bandyopadhyay GK, Imagawa W, Wallace D and Nandi S (1987) Linoleate metabolites enhance thein vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J Biol Chem 262: 2750–2756.Google Scholar
  6. Barnes D and Sato GH (1980a) Methods for growth of cultured cells in serum free-medium. Anal Biochem 102: 255–270.Google Scholar
  7. Barnes D and Sato GH (1980b) Serum-free cell culture: A unifying approach. Cell 22: 649–655.Google Scholar
  8. Bartoli GM, Bartoli S, Galeotti T and Bertoli E (1980) Superoxide dismutase content and microsomal lipid composition of tumours with different growth rates. Biochim Biophys Acta 620: 205–211.Google Scholar
  9. Baud L, Sraer J, Perez J, Nivez M-P and Ardaillou R (1985) Leukotriene C4 binds to human glomerular epithelial cells and promotes their proliferationin vitro. J Clin Invest 76: 374–377.Google Scholar
  10. Begin ME, Ells G, Das UN and Horrobin DF (1986) Differential killing of human carcinoma cells supplemented withn−3 andn−6 polyunsaturated fatty acids. J Natl Cancer Inst 77: 1053–1062.Google Scholar
  11. Begin ME (1987) Effects of polyunsaturated fatty acids and of their oxidation products on cell survival. Chem Phys Lipids 45: 269–313.Google Scholar
  12. Begin ME, Ells G and Horrobin DF (1988) Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 80: 188–194.Google Scholar
  13. Bettger WJ and Ham RG (1982) The nutrient requirements of cultured mammalian cells. Adv Nutr Res 4: 249–286.Google Scholar
  14. Bhuyan BK, Adams EC, Badiner CJ, Li LH and Barden K (1986) Cell cycle effects of prostaglandins A1, A2, and D2 in human murine melanoma cells in culture. Cancer Res. 46: 1688–1693.Google Scholar
  15. Bird RP and Draper HH (1980) Effect of malonaldehyde and acetaldehyde on cultured mammalian cells: Growth, morphology, and synthesis of macromolecules. J Toxicol Env Health 6: 811–823.Google Scholar
  16. Bjaere U (1987) Serum-free cultivation of lymphoid cells. In: Fiechter A. (ed.) Advances in Biochemical Engineering/Biotechnology. (pp. 95–109) Springer-Verlag, Berlin.Google Scholar
  17. Boni LT and Rando RR (1985) The nature of protein kinase C activation by physically defined phospholipid vesicles and diacylglycerols. J Biol Chem 260: 10819–10825.Google Scholar
  18. Borrás M and Leclercq G (1992) Modulatory effect of nonesterified fatty acids on structure and binding characteristics of estrogen receptor from MCF-7 human breast cancer cells. J Receptor Res 12: 463–484.Google Scholar
  19. Borys MC, Linzer DIH and Papoutsakis ET (1993) Culture pH affects expression rates and glycosylation of recombinant mouse placental Iactogen proteins by Chinese hamster ovary (CHO) cells. Biotechnology 11: 720–724.Google Scholar
  20. Buege JA and Aust SD (1978) Microsomal lipid peroxidation. Meth Enzymol 52: 302–310.Google Scholar
  21. Carroll KK and Hopkins GJ (1979) Dietary polyunsaturated fat versus saturated fat in relation to mammary carcinogenesis. Lipids 14: 155–158.Google Scholar
  22. Carty TJ, Eskra JD, Lomberdino JG and Hoffman WW (1980a) Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity study. Prostaglandins 19: 51–59.Google Scholar
  23. Carty TJ, Stevens JS, Lombardino JG, Pany MJ and Randall MJ (1980b) Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition. Prostaglandins 19: 671–682.Google Scholar
  24. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U and Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847–7851.Google Scholar
  25. Cave Jr, WT (1991) Dietaryn−3 (ω−3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J 5: 2160–2166.Google Scholar
  26. Cheeseman KH, Burton GW, Ingold KU and Slater TF (1984) Lipid peroxidation and lipid antioxidants in normal and tumor cells. Toxicol Pathol 22: 235–239.Google Scholar
  27. Chegini N and Safa AR (1987) Morphological alterations induced by prostaglandins E1,F and A1 in MDA-MB-231 and MCF-7 human breast cancer cell lines. Cancer Lett 37: 189–197.Google Scholar
  28. Conde B, Tejedor M, Sinues E and Alcala A (1991) Modulation of cell growth and differentiation induced by prostaglandin D2 in the glioma cell line C6. Anticancer Res 11: 289–296.Google Scholar
  29. Conn PM, Ganong BR, Ebeling J, Staley D, Neidel JE and Bell RM (1985) Diacylglycerols release LH: Structure-activity relations reveal a role for protein kinase C. Biochem Biophys Res Commun 126: 532–539.Google Scholar
  30. Cook HW, Byers DM, Palmer FBStC, Spence MW, Rakoff H, Duvall SM and Emken EA (1991) Alternate pathways in the desaturation and chain elongation of linolenic acid, 18∶3(n−3), in cultured glioma cells. J Lipid Res 32: 1265–1273.Google Scholar
  31. Cook SJ and McCormick F (1993) Inhibition by cAMP of Rasdependent activation of Raf. Science 262: 1069–1072.Google Scholar
  32. Corey EJ, Shih C and Cashman JR (1983) Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 80: 3581–3584.Google Scholar
  33. Cornwell DG and Morisaki N (1984) Fatty acid paradoxes in the control of cell proliferation: Prostaglandins, lipid peroxides and cooxidation reactions. In: Pryor WA. (ed.) Free Radicals in Biology. (pp. 95–148) Academic Press, Orlando.Google Scholar
  34. Danielson UH, Esterbauer H and Mannervik B (1987) Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. Biochem J 247: 707–713.Google Scholar
  35. Davison PM and Karasek MA (1981) Human dermal microvascular endothelial cellsin vitro: Effect of cyclic AMP on cellular morphology and proliferation rate. J Cell Phys 106: 253–258.Google Scholar
  36. Diplock AT, Balasubramanian KA, Manohar M, Mathan VI and Ashton D (1988) Purification and chemical characterisation of the inhibitor of lipid peroxidation from intestinal mucosa. Biochim Biophys Acta 962: 42–50.Google Scholar
  37. Doi O, Doi F, Schroeder F, Alberts AW and Vagelos PR (1978) Manipulation of fatty acid composition of membrane phospholipid and its effects on cell growth in mouse LM cells. Biochim Biophys Acta 509: 239–250.Google Scholar
  38. Dugas B, Paul-Eugene N, Cairns J, Gordon J, Calenda A, Mencia-Huerta JM and Braquet P (1990) Leukotriene B4 potentiates the expression and release of FCeRII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL4. J Immunol 145: 3406–3411.Google Scholar
  39. Dunbar LM and Bailey JM (1975) Enzyme deletions and essential fatty acid metabolism in cultured cells. J Biol Chem 250: 1152–1153.Google Scholar
  40. Durant S, Duval D and Homo-Delarche F (1989) Effect of exogenous prostaglandins and nonsteroidal anti-inflammatory agents on prostaglandin secretion and proliferation of mouse embryo fibroblasts in culture. Prostaglandins Leukotrienes Essential Fatty Acids 38: 1–8.Google Scholar
  41. Eisenbarth GS, Wellman DK and Lebovitz HE (1974) Prostagndin A1 inhibition of chondrosarcoma growth. Biochem Biophys Res Commun 60: 1302–1308.Google Scholar
  42. Esterbauer H, Zollner H and Lang J (1985) Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem J 228: 363–373.Google Scholar
  43. Esterbauer H, Eckl P and Ortner A (1990) Possible mutagens derived from lipids and lipid precursors. Mutation Res 238: 223–233.Google Scholar
  44. Evans VJ, Bryant JC, Kerr HA and Schilling EL (1964) Chemically defined media for cultivation of long-term cell strains from four mammalian species. Exp Cell Res 36: 439–474.Google Scholar
  45. Field CJ, Ryan EA, Thomson ABR and Clandinin MJ (1990) Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 265: 11143–11150.Google Scholar
  46. Fischer S and Weber PC (1984) Prostaglandn I3 is formedin vivo in man after dietary eicosapentaenoic acid. Nature 307: 165–168.Google Scholar
  47. Fischer SM, Cameron GS, Baldwin JK, Jasheway DW, Patrick KE and Belury MA (1989) The arachidonic acid cascade and multistage carcinogenesis in mouse skin. In: Slaga TJ (ed.) Skin Carcinogenesis: Mechanisms and Human Relevance. (pp. 249–264) A. R. Liss, New York.Google Scholar
  48. Fukushima M, Kato T, Ueda R, Ota K, Narumiya S and Hayaishi O (1982) Prorlaglandin D2, a potential antineoplastic agent. Biochem Biophys Res Commun 105: 956–964.Google Scholar
  49. Galeotti T, Masotti L, Borello S and Casali E (1991) Oxy-radical metabolism and control of tumour growth. Xenobiotica 21: 1041–1051.Google Scholar
  50. Ginsberg BH, Brown TJ, Simon I and Spector AA (1981) Effect of the membrane lipid environment on the properties of insulin receptors. Diabetes 30: 773–780.Google Scholar
  51. Glassy MC, Tharakan JP and Chau PC (1988) Serum-free media in hybridoma culture and monoclonal antibody production. Biotechnol Bioeng 32: 1015–1028.Google Scholar
  52. Gower JD (1988) A role for dietary lipids and antioxidants in the activation of carcinogens. Free Radical Biol Med 5: 95–111.Google Scholar
  53. Grammatikos SI, Subbaiah PV, Victor TA and Miller WM (1994a) Diversity in the ability of cultured cells to elongate and desaturate essential (n−6 andn−3) fatty acids. Ann NY Acad Sci 745: 92–105.Google Scholar
  54. Grammatikos SI, Subbaiah PV, Victor TA and Miller WM (1994b) (n−3 andn−6) fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br J Cancer 70: 219–227.Google Scholar
  55. Higuchi K (1973) Cultivation of animal cells in chemically defined media: A review. Adv Appl Microbiol 16: 111–136.Google Scholar
  56. Holian O and Nelson R (1992) Action of long-chain fatty acids on protein kinase C activity: Comparison of omega-6 and omega-3 fatty acids. Anticancer Res 12: 975–980.Google Scholar
  57. Honn KV, Bockman RS and Marnett LJ (1981a) Prostaglandins and cancer: A review of tumor initiation through tumor metastasis. Prostaglandins 21: 833–864.Google Scholar
  58. Honn KV, Cicone B and Skoff A (1981b) Prostacyclin: A potent antimetastatic agent. Science 212: 1270–1272.Google Scholar
  59. Hornstra G, Christ-Hazelhof E, Haddeman E, ten Hoor F and Nugteren DH (1981) Fish oil feeding lowers thromboxane and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3. Prostaglandins 21: 727–738.Google Scholar
  60. Horrobin DF (1990) Essential fatty acids, lipid peroxidation, and cancer. In: Horrobin DF. (ed.) Omega-6 Fatty Acids: Pathophysiology and Roles in Clinical Medicine (pp. 351–377) A.R. Liss, New York.Google Scholar
  61. Huang JM-C, Xian H and Bacaner M (1992) Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci USA 89: 6452–6456.Google Scholar
  62. Hubbard NE and Erickson KL (1987) Enhancement of metastasis from a transplantable mouse mammary tumor by dietary linoleic acid. Cancer Res 47: 6171–6175.Google Scholar
  63. Huttner JJ, Gwebu ET, Panganamala RV, Milo GE and Cornwell DG (1977) Fatty acids and their prostaglandin derivatives: Inhibitors of proliferation in aortic smooth muscle cells. Science 197: 289–291.Google Scholar
  64. Iturralde M, González B and Pineiro A (1990) Linoleate and linolenate desaturation by rat hepatoma cells. Biochem Intl 20: 37–43.Google Scholar
  65. Jimenez de Asua L, Clingan D and Rudland PS (1975) Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F. Proc Natl Acad Sci USA 72: 2724–2728.Google Scholar
  66. Johnson GS and Pastan I (1971) Change in growth and morphology of fibroblasts by prostaglandins. J Natl Cancer Inst 47: 1357–1364.Google Scholar
  67. Kano-Sueoka T, King DM, Fisk HA and Klug SJ (1990) Binding of epidermal growth factor to its receptor is affected by membrane phospholipid environment. J Cell Physiol 145: 543–548.Google Scholar
  68. Kantor HS and Hampton M (1978) Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase. Nature 276: 841–842.Google Scholar
  69. Kaplan L, Weiss J and Elsbach P (1978) Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes. Proc Natl Acad Sci USA 75: 2955–2958.Google Scholar
  70. Karmali RA (1987) Fatty acids: inhibition. Am J Clin Nutr 45: 225–229.Google Scholar
  71. Katz EB and Boylan ES (1987) Stimulatory effect of high polyunsaturated fat diet on lung metastasis from the 13762 mammary adenocarcinoma in female retired breeder rats. J Natl Cancer Inst 79: 351–358.Google Scholar
  72. Keyaki A, Handa H, Yamashita J, Tokuriki Y, Otsuka S-I, Yamasaki T and Gi H (1984) Growth-inhibitory effect of prostaglandin D2 on mouse glioma cells. J Neurosurg 61: 912–917.Google Scholar
  73. Khan WA, Blobe GC and Hannun YA (1992) Activation of protein kinase C by oleic acid. Determination and analysis of inhibition by detergent micelles and physiologic membranes: Requirement for free oleate. J Biol Chem 267: 3605–3612.Google Scholar
  74. Kigoshi T, Uchida K, Kaneko M, Iwasaki R, Nakano S, Azukizawa S and Morimoto S (1990) Direct inhibition of smooth muscle light chain kinase by arachidonic acid in a purified system. Biochem Biophys Res Commun. 171: 369–374.Google Scholar
  75. King ME and Spector AA (1978) Effects of specific fatty acyl enrichments on membrane physical properties detected with a spin label probe. J Biol Chem 253: 6493–6501.Google Scholar
  76. Lai CS, Hopwood LE and Swartz HM (1980) Electron spin resonance studies of changes in membrane fluidity of Chinese hamster ovary cells during the cell cycle. Biochim Biophys Acta 602: 117–126.Google Scholar
  77. Lamé MW and Segall HJ (1986) Metabolism of the pyrrolizidine alkaloid metabolite trans-4-hydroxy-2-hexanal by mouse liver aldehyde dehydrogenases. Toxicol Appl Pharmaol 82: 94–103.Google Scholar
  78. Léger CL, Daveloose D, Christon R and Viret J (1990) Evidence for a structurally specific role of essential polyunsaturated fatty acids depending on their peculiar double-bond distribution in biomembranes. Biochemistry 29: 7269–7275.Google Scholar
  79. Maeda M, Doi O and Akamatsu Y (1978) Metabolic conversion of polyunsaturated fatty acids in mammalian cultured cells. Biochim Biophys Acta 530: 153–164.Google Scholar
  80. Marini S, Palamara AT, Garaci E and Santoro MG (1990) Growth inhibition of Friend erythroleukaemia cell tumoursin vivo by a synthetic analogue of prostaglandin A: an action independent of natural killer-activity. Br J Cancer 61: 394–399.Google Scholar
  81. Marra CA and De Alaniz MJT (1992) Incorporation and metabolic conversion of saturated and unsaturated fatty acids in SK-Hep1 human hepatoma cells in culture. Mol Cell Biochem 117: 107–118.Google Scholar
  82. McCumbee WD, Harrelson JM and Lebovitz HE (1983) Hormonal and metabolic regulation of human chondrosarcomain vitro. Cancer Res 43: 513–516.Google Scholar
  83. McPhail LC, Clayton C and Snyderman R (1984) A potential second messenger role for unsaturated fatty acids: Activation of Ca2+-dependent protein kinase. Science 224: 622–624.Google Scholar
  84. Medrano EE, Farooqui JZ, Boissy RE, Boissy YL, Akadiri B and Nordlund JJ (1993) Chronic growth stimulation of human adult melanocytes by inflammatory mediatorsin vitro: Implications for nevus formation and initial steps in melanocyte oncogenesis. Proc Natl Acad Sci USA 90: 1790–1794.Google Scholar
  85. Miller AM, Cullen MK, Kobb SM and Weiner RS (1989) Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth. J Lab Clin Med 113: 355–361.Google Scholar
  86. Modat G, Muller A, Mary A, Grégoire C and Bonne C (1987) Differential effects of leukotrienes B4 and C4 on bovine aortic endothelial cell proliferationin vitro. Prostaglandins 33: 531–538.Google Scholar
  87. Moncada S and Vane JR (1979) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 30: 293–331.Google Scholar
  88. Naval J, Martinez-Lorenzo MJ, Marzo I, Desportes P and Pineiro A (1993) Alternative route for the biosynthesis of polyunsaturated fatty acids in K562 cells. Biochem J 291: 841–845.Google Scholar
  89. Neichi T, Koshihara Y and Murota S (1983) Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim Biophys Acta 753: 130–132.Google Scholar
  90. Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661–665.Google Scholar
  91. Nishizuka Y (1989) Studies and prospectives of the protein kinase C family for cellular regulation. Cancer 63: 1892–1903.Google Scholar
  92. Penning TM and Talalay P (1983) Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins. Proc Natl Acad Sci USA 80: 4504–4508.Google Scholar
  93. Piomelli D, Wang JKT, Sihra TS, Nairn AC, Czernik AJ and Greengard P (1989) Inhibition of Ca2+/calmodulin-dependent protein kinase II by arachidonic acid and its metabolites. Proc Natl Acad Sci USA 86: 8550–8554.Google Scholar
  94. Poon R, Richards JM and Clark WR (1981) The relationship between plasma membrane lipid composition and physical-chemical properties. II. Effect of phospholipid fatty acid modulation on plasma membrane physical properties and enzymatic activities. Biochim Biophys Acta 649: 58–66.Google Scholar
  95. Pritchard GA, Jones DL and Mansel RE (1989) Lipids in breast carcinogenesis. Br J Surg 76: 1069–1073.Google Scholar
  96. Pryor WA and Stanley JP (1975) A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 40: 3615–3617.Google Scholar
  97. Rhee SG, Suh P-G, Ryu S-H and Lee SY (1989) Studies of inositol phospholipid-specific phospholipase C. Science 244: 546–550.Google Scholar
  98. Rintoul DA, Sklar LA and Simoni RD (1978) Membrane lipid modification of Chinese hamster ovary cells. Thermal properties of membrane phospholipids. J Biol Chem 253: 7447–7452.Google Scholar
  99. Rola-Pleszczynski M and Stankova J (1992) Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytesin vitro: transcriptional and posttranscriptional mechanisms. Blood 80: 1004–1011.Google Scholar
  100. Rose DP (1986) Dietary factors and breast cancer. Cancer Surveys 5: 671–687.Google Scholar
  101. Rose DP and Conolly JM (1990) Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line. Cancer Res 50: 7139–7144.Google Scholar
  102. Rosenthal MD (1987) Fatty acid metabolism of isolated mammalian cells. Prog Lipid Res 26: 87–124.Google Scholar
  103. Sakai T, Yamaguchi N, Kawai K, Nishino H and Iwashima A (1984) Prostaglandin D2 inhibits the proliferation of human malignant tumor cells. Prostaglandins 27: 17–26.Google Scholar
  104. Salem Jr N (1989) Omega-3 fatty acids: Molecular and biochemical aspects. In: Scala J and Spiller GA (eds.) New Protective Roles for Selected Nutrients. (pp. 109–228) A. R. Liss, New York.Google Scholar
  105. Samuelsson B (1983) Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568–575.Google Scholar
  106. Santoro MG, Philpott GW and Jaffe BM (1976) Inhibition of tumour growthin vivo andin vitro by prestaglandin E. Nature 263: 777–779.Google Scholar
  107. Santoro MG, Crisari A, Benedetto A and Amici C (1986) Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: Antiproliferative action of prostaglandin A. Cancer Res 46: 6073–6077.Google Scholar
  108. Sardesai VM (1992) The essential fatty acids. Nutr Clin Practice 7: 179–186.Google Scholar
  109. Schmid G (1990) Lipid metabolism of animal cells in culture-A review. In: Spier RE, Griffiths JB and Meignier B. (eds.) Production of Biologicals from Animal Cells in Culture. (pp. 61–66) Butterworth-Heinemann, Stoneham, MA.Google Scholar
  110. Schmid G, Zilg H, Eberhard U and Johannsen R (1991) Effect of free fatty acids and phospholipids on growth of and product formation by recombinant baby hamster kidney (rBHK) and Chinese hamster ovary (rCHO) cells in culture. J Biotechnol 17: 155–167.Google Scholar
  111. Shen TY and Winter CA (1977) Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res: 12: 90–245.Google Scholar
  112. Silberstein GB, Strickland P, Trumpbour V, Coleman S and Daniel CW (1984)In vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts. Proc Natl Acad Sci USA 81: 4950–4954.Google Scholar
  113. Simmet T and Jaffe BM (1983) Inhibition of B-16 melanoma growthin vitro by prostaglandin D2. Prostaglandins 25: 47–54.Google Scholar
  114. Skouteris GG and McMenamin M (1992) Transforming growth factor-α-induced DNA synthesis andc-myc expression in primary rat hepatocyte cultures is modulated by indomethacin. Biochem J 281: 729–733.Google Scholar
  115. Spector AA, Kiser KE, Denning GM, Koh S-WM and DeBault LE (1979) Modification of the fatty acid composition of cultured human fibroblasts. J Lipid Res 20: 536–547.Google Scholar
  116. Spector AA, Mathur SN, Kaduce TL and Hyman BT (1981) Lipid nutrition and metabolism of cultured mammalian cells. Prog Lipid Res 19: 155–186.Google Scholar
  117. Spector AA, Kaduce TL, Figard PH, Norton KC, Hoak JC and Czervionke RL (1983) Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. J Lipid Res 24: 1595–1604.Google Scholar
  118. Spector AA and Yorek M (1985) Membrane lipid composition and cellular function. J Lipid Res 26: 1015–1035.Google Scholar
  119. Spector AA and Burns CP (1987) Biological and therapeutic potential of membrane lipid modification in tumors. Cancer Res 47: 4529–4537.Google Scholar
  120. Sprecher H (1981) Biochemistry of essential fatty acids. Prog Lipid Res 20: 13–22.Google Scholar
  121. Stampfer MR (1982) Cholera toxin stimulation of human mammary epithelial cells in culture. In Vitro 18: 531–537.Google Scholar
  122. Stryer L (1988) Biochemistry. Freeman and Company, New York.Google Scholar
  123. Suzuki K, Kobayashi N, Moriya Y, Abiko Y, and Suzuki H (1988) Inhibition of human gingival carcinoma cell growth by prostaglandins. Gen Pharmac 19: 273–276.Google Scholar
  124. Takaoka T and Katsuta H (1971) Long-term cultivation of mammalian cell strains in protein- and lipid-free chemically defined synthetic media. Exp Cell Res 67: 295–304.Google Scholar
  125. Taylor-Papadimitriou J, Purkis P and Fentiman IS (1980) Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cells. J Cell Phys 102: 317–321.Google Scholar
  126. Tinoco J (1982) Dietary requirement and functions of α-linolenic acid in animals. Prog Lipid Res 21: 1–45.Google Scholar
  127. Tiwari RK, Mukhopadhyay B, Telang NT and Osborne MP (1991) Modulation of gene expression by selected fatty acids in human breast cancer cells. Anticancer Res 11: 1383–1388.Google Scholar
  128. Tobias LD and Hamilton JG (1979) The effect of 5,8,11,14-eicosatetraynoic acid on lipid metabolism. Lipids 14: 181–193.Google Scholar
  129. Tocher DR (1993) Elongation predominates over desaturation in the metabolism of 18∶3n−3 and 20∶5n−3 in turbot (Scopthalmus maximus) brain astroglial cells in primary culture. Lipids 28: 267–272.Google Scholar
  130. Utsumi K, Yamamoto G and Inaba K (1965) Failure of Fe2+-induced lipid peroxidation and swelling in the mitochondria isolated from ascites tumor cells. Biochim Biophys Acta 105: 368–371.Google Scholar
  131. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 278: 456–459.Google Scholar
  132. Wicha MS, Liotta LA and Kidwell WR (1979) Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells. Cancer Res 39: 426–435.Google Scholar
  133. Willis AL and Smith DL (1989) Dihomo-gamma-linolenic and gamma-linolenic acids in health and disease. In: Spiller GA and Scala J (eds.) New Protective Roles for Selected Nutrients. (pp. 39–108) A.R. Liss, New York.Google Scholar
  134. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ and Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065–1069.Google Scholar
  135. Yang I, Guzman R, Richarda J, Imagawa W, McCormick K and Nandi S (1980) Growth factor- and cyclic nucleotide-induced proliferation of normal and malignant mammary epithelial cells in primary culture. Endocrinology 107: 35–41.Google Scholar
  136. Yoneda T, Kitamura M, Ogawa T, Aya S and Sakuda M (1985) Control of VX2 carcinoma cell growth in culture by calcium, calmodulin, and prostaglandins. Cancer Res 45: 398–405.Google Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • Stephanos I. Grammatikos
    • 1
  • Papasani V. Subbaiah
    • 2
  • Thomas A. Victor
    • 3
  • William M. Miller
    • 1
  1. 1.Department of Chemical EngineeringNorthwestern UniversityEvanstonUSA
  2. 2.Departments of Biochemistry and MedicineRush Medical CollegeChicagoUSA
  3. 3.Department of PathologyNorthwestern University Medical School, Evanston HospitalEvanstonUSA

Personalised recommendations